Pathological features and prognostication in colorectal cancer
The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined
by the Union for International Cancer Control (UICC) and American Joint Committee on …
by the Union for International Cancer Control (UICC) and American Joint Committee on …
The role of heavy metals in the development of colorectal cancer
Y Li, J Lou, S Hong, D Hou, Y Lv, Z Guo, K Wang, Y Xu… - BMC cancer, 2023 - Springer
Objective To investigate the relationship among 18 heavy metals, microsatellite instability
(MSI) status, ERCC1, XRCC1 (rs25487), BRAF V600E and 5 tumor markers and their role in …
(MSI) status, ERCC1, XRCC1 (rs25487), BRAF V600E and 5 tumor markers and their role in …
Current perspectives on the importance of pathological features in prognostication and guidance of adjuvant chemotherapy in colon cancer
K Chen, H Wang, G Collins, E Hollands, IYJ Law… - Current …, 2022 - mdpi.com
There is not a clear consensus on which pathological features and biomarkers are important
in guiding prognosis and adjuvant therapy in colon cancer. The Pathology in Colon Cancer …
in guiding prognosis and adjuvant therapy in colon cancer. The Pathology in Colon Cancer …
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study
Background and aim Recent studies have proposed that commensal bacteria might be
involved in the development and progression of gastrointestinal disorders such as colorectal …
involved in the development and progression of gastrointestinal disorders such as colorectal …
Identification of antisense and sense RNAs of intracrine fibroblast growth factor components as novel biomarkers in colorectal cancer and in silico studies for drug and …
L Rejali, E Nazemalhosseini-Mojarad, L Valle… - Environmental …, 2023 - Elsevier
Introduction Colorectal cancer (CRC) is one of the most malignant tumors and in which
various efforts for screening is inconclusive. The intracrine FGF panel, the non-tyrosine …
various efforts for screening is inconclusive. The intracrine FGF panel, the non-tyrosine …
[HTML][HTML] Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value
HM Ahn, DW Kim, HJ Oh, HK Kim, HS Lee… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Approximately 40% of colorectal cancer (CRC) cases are linked to Kirsten
rat sarcoma viral oncogene homolog (KRAS) mutations. KRAS mutations are associated …
rat sarcoma viral oncogene homolog (KRAS) mutations. KRAS mutations are associated …
Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients
Z Mosaferi, M Pirestani, E Arefian, G Gojani… - Journal of …, 2024 - Springer
Background Patients with colorectal cancer can benefit from anti-EGFR (epidermal growth
factor receptor) therapy. However, this therapy is not effective for treating colorectal cancers …
factor receptor) therapy. However, this therapy is not effective for treating colorectal cancers …
KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients
Z Mirzapoor Abbasabadi, D Hamedi Asl… - Journal of clinical …, 2023 - Wiley Online Library
Abstract Aim Mutations in KRAS, NRAS, BRAF, and PIK3CA genes are critical factors in
clinical evaluation of colorectal cancer (CRC) development and progression. In Iran …
clinical evaluation of colorectal cancer (CRC) development and progression. In Iran …
Mutation status and prognostic value of KRAS and BRAF in Southeast Iranian colorectal cancer patients: first report from Southeast of Iran
Abstract Main Purpose This study aimed to determine any association of KRAS and BRAF
mutations in colorectal cancer with clinicopathological features and overall survival (OS) of …
mutations in colorectal cancer with clinicopathological features and overall survival (OS) of …
Can hypoxia-inducible factor-1α overexpression discriminate human colorectal cancers with different microsatellite instability?
Clinicopathological features of high-frequency microsatellite instability (MSI-H) colorectal
cancers (CRCs) are different from low-frequency MSI (MSI-L) and microsatellite stable …
cancers (CRCs) are different from low-frequency MSI (MSI-L) and microsatellite stable …